XTL Biopharmaceuticals Ltd. Aktie - Unternehmensdaten & Kurse - IL0010854979 | goSPATZ

XTL Biopharmaceuticals Ltd.

Share · IL0010854979 (XTAE)

No Price

Closing Price XTAE 22.10.2025: 4,40 ILA

22.10.2025 09:15

Current Prices from XTL Biopharmaceuticals Ltd.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
TASE	XTLB.TA	ILA	22.10.2025 09:15	4,40 ILA	0,00 ILA

Share Float & Liquidity

Free Float 72,14 %

Shares Float 635,81 M

Shares Outstanding 881,39 M

Company Profile for XTL Biopharmaceuticals Ltd. Share

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

Company Data

Name XTL Biopharmaceuticals Ltd.

Company XTL Biopharmaceuticals Ltd.

Website https://www.xtlbio.com

Primary Exchange

TASE

ISIN IL0010854979

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Noam Band

Market Capitalization 43 Mio

Country Israel

Currency ILA

Employees 0,0 T

Address 5 Badner Street, 5218102 Ramat Gan

IPO Date 2005-08-30

Ticker Symbols

Name	Symbol
TASE	XTLB.TA

More Shares

Investors who hold XTL Biopharmaceuticals Ltd. also have the following shares in their portfolio:

JP SM.CAP.FD DL-,10 Fund

SPERMOSENS AB Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025